An innovative floating gastro retentive dosage system: Formulation and in vitro evaluation - Archive ouverte HAL Access content directly
Journal Articles International Journal of Pharmaceutics Year : 2009

An innovative floating gastro retentive dosage system: Formulation and in vitro evaluation

Abstract

Over the years, different formulation technologies intended for gastro retentive dosage delivery were investigated and patented. The aim of this study was to develop an innovative floating gastro retentive dosage form (GRDF). The developed technology induces a low-density dosage form containing high active pharmaceutical ingredient (API) concentration by using a hydrophobic dusty powder excipient under specific conditions. The new dosage form was obtained by state of the art wet granulation manufacturing process. An experimental design using a discrete variable and four mixture variables was conducted in order to optimize API concentration and buoyancy of the new dosage form. An apparatus was developed to measure the apparent density of floating tablet. The GRDF was characterized for apparent density, buoyancy, porosity and dissolution using in vitro experimentations.
Not file

Dates and versions

hal-01432996 , version 1 (17-01-2017)

Identifiers

Cite

Christophe Sauzet, M Claeys-Bruno, Maxime Nicolas, J Kister, P Piccerelle, et al.. An innovative floating gastro retentive dosage system: Formulation and in vitro evaluation. International Journal of Pharmaceutics, 2009, 378, pp.23 - 29. ⟨10.1016/j.ijpharm.2009.05.027⟩. ⟨hal-01432996⟩
42 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More